Insider · CIK 0001877611
Dean Zikria
Files at VBIO (Valion Bio, Inc.). First filing -, latest -.
In brief
Dean Zikria files SEC Form 4 as director and CEO at VBIO (Valion Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dean Zikria has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | VBIO Valion Bio, Inc. | AGrant or award Restricted Stock Unitsderivative | +50,000 | $0.00 | $0 | 50,000 | 19 d ago |
| Aug 6, 2025 | VBIO Valion Bio, Inc. | AGrant or award Stock Option (Right to Purchase)derivative | +7,500 | $0.00 | $0 | 7,500 | Aug 8, 2025 |
| Dec 18, 2024 | VBIO Valion Bio, Inc. | AGrant or award Stock Option (Right to Purchase)derivative | +12,000 | $0.00 | $0 | 12,000 | Dec 20, 2024 |
Questions about Dean Zikria
Answered from the filings on this page, as of the latest one.
Is Dean Zikria buying or selling?
Dean Zikria has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dean Zikria's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dean Zikria has 0.
Where does Dean Zikria file Form 4?
Dean Zikria has filed Form 4 at VBIO (Valion Bio, Inc.) as Interim CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.